Laurel Wealth Advisors (California)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$4.23M Buy
82,624
+3,066
+4% +$147K 0.42% 59
2022
Q3
$3.48M Sell
79,558
-14,151
-15% -$688K 0.37% 72
2022
Q2
$4.91M Sell
93,709
-2,606
-3% -$133K 0.5% 44
2022
Q1
$4.99M Sell
96,315
-34,644
-26% -$1.8M 0.41% 57
2021
Q4
$7.73M Buy
130,959
+33,960
+35% +$1.68M 0.6% 29
2021
Q3
$4.17M Sell
96,999
-8,717
-8% -$386K 0.77% 22
2021
Q2
$4.14M Buy
105,716
+12,719
+14% +$495K 0.54% 42
2021
Q1
$3.37M Sell
92,997
-4,757
-5% -$169K 0.51% 42
2020
Q4
$3.6M Buy
97,754
+21,932
+29% +$804K 0.53% 44
2020
Q3
$2.64M Buy
75,822
+2,387
+3% +$83.7K 0.44% 58
2020
Q2
$2.28M Buy
73,435
+6,745
+10% +$229K 0.42% 60
2020
Q1
$2.07M Sell
66,690
-5,198
-7% -$177K 0.47% 53
2019
Q4
$2.67M Sell
71,888
-15,585
-18% -$555K 0.45% 55
2019
Q3
$2.98M Buy
87,473
+17,672
+25% +$643K 0.51% 46
2019
Q2
$2.87M Sell
69,801
-442
-0.6% -$17.6K 0.63% 36
2019
Q1
$2.83M Buy
70,243
+62,253
+779% +$2.49M 0.7% 31
2018
Q4
$330K Sell
7,990
-64,246
-89% -$2.67M 0.1% 236
2018
Q3
$3.02M Buy
72,236
+2,710
+4% +$104K 0.74% 29
2018
Q2
$2.39M Buy
69,526
+6,027
+9% +$206K 0.64% 36
2018
Q1
$2.14M Sell
63,499
-4,597
-7% -$158K 0.66% 36
2017
Q4
$2.34M Buy
68,096
+8,294
+14% +$283K 0.67% 33
2017
Q3
$2.02M Sell
59,802
-1,303
-2% -$41.9K 0.68% 32
2017
Q2
$1.95M Buy
61,105
+1,950
+3% +$61.5K 0.69% 32
2017
Q1
$1.92M Buy
59,155
+5,249
+10% +$165K 0.74% 27
2016
Q4
$1.66M Buy
53,906
+18,056
+50% +$551K 0.74% 29
2016
Q3
$1.15M Sell
35,850
-794
-2% -$26.5K 0.54% 54
2016
Q2
$1.22M Buy
36,644
+2,703
+8% +$86.3K 0.59% 45
2016
Q1
$954K Sell
33,941
-1,231
-3% -$35.2K 0.48% 57
2015
Q4
$1.08M Buy
+35,172
New +$1.11M 0.56% 52

Other funds holding PFE